Dear Colleagues,

Nanoscience and nanotechnology represent a rapidly growing area of research consisting of fields such as pharmacy, chemistry, biology and medicine. Nanomaterials with unique physicochemical properties offer great opportunities and challenges for researchers in biomedical areas. Nanotechnology approaches used in nanomedicine have proved to be an effective alternative for anticancer and antimicrobial treatment options. Cancer and microbial infections can cause dangerous, life-threatening invasive infections and are found to be resistant to a wide range of anticancer drugs and antibiotics, respectively. Notably, multidrug-resistant bacteria represent a major concern in public health as they can destroy the potency of the existing antibiotics. Hence, novel strategies are not only required but are vital to fight against antimicrobial resistance. Meanwhile, nanomedicine plays a pivotal role when it comes to developing alternative and more effective treatment strategies for malignancies and for microbial infections under the abovementioned circumstances.

This Research Topic covers a broad range of nanotechnology-based theragnostic approaches to be used for nanomedicine, biosensing, bioimaging, the biocompatibility of nano-biomaterials, as well as drug delivery systems (including but limited to polymeric nanocomposites, metallic nanocomposites, carbon-based nano systems, nanofibers, and proteins) with the ultimate goal to combat malignancies and microbial infections.

This Topic will focus on the recent and novel findings among scientists and researchers on the developments of emerging nanotechnology-enabled theragnostic approaches for malignancies and microbial infections. We welcome a wide range of submissions, including Original Research, Review, Mini-reviews and Commentaries articles, including but not limited to the following subject matter:

• Diagnostic and therapeutic applications of a broad range of nano systems, including liposome formulation, cyclodextrin drug carriers, solid lipid nanoparticles, metal-based nanoparticles, porphyrin-based nanomaterials, polymeric drug encapsulation delivery systems, self–micro emulsifying drug delivery systems, nanocrystals, hydrosol colloidal dispersions, microemulsions, solid dispersions, cosolvent use, dendrimers, polymer-drug conjugates, polymeric micelles, and mesoporous silica nanoparticles
• Synthesis of metal-nanosome clusters and their novel theragnostic applications
• Targeted drug delivery, drug loading and controlled release of drugs, extracellular vesicles and nanoantibody, nanomaterials for immuno-oncology, active and passive delivery of nanoparticles into cells
• Tumoral delivery of nanotherapeutics and immune-targeted nanomedicine
• Use of exosomes in future theragnostic materials and as biomarkers for cancer therapy
• Multifunctional nanomaterials for targeting cancer nanotheranostics, and nano-based photothermal cancer therapy approaches
• Green Nanomaterials to Combat Microbial Infection and Cancer

Dr. Ebrahim Mostafavi
Prof. Dr. Muthupandian Saravanan
Dr. Hamed Barabadi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• nanomaterials
• therapeutics
• diagnostics
• cancer nanotheranostics
• antimicrobial